These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8651950)

  • 1. Modulation effects of cyclosporine on etoposide pharmacokinetics and CNS distribution in the rat utilizing microdialysis.
    Burgio DE; Gosland MP; McNamara PJ
    Biochem Pharmacol; 1996 Apr; 51(7):987-92. PubMed ID: 8651950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution.
    Burgio DE; Gosland MP; McNamara aPJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):911-7. PubMed ID: 9864272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
    Lum BL; Kaubisch S; Yahanda AM; Adler KM; Jew L; Ehsan MN; Brophy NA; Halsey J; Gosland MP; Sikic BI
    J Clin Oncol; 1992 Oct; 10(10):1635-42. PubMed ID: 1403041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.
    Lum BL; Fisher GA; Brophy NA; Yahanda AM; Adler KM; Kaubisch S; Halsey J; Sikic BI
    Cancer; 1993 Dec; 72(11 Suppl):3502-14. PubMed ID: 7902206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.
    Yahanda AM; Alder KM; Fisher GA; Brophy NA; Halsey J; Hardy RI; Gosland MP; Lum BL; Sikic BI
    J Clin Oncol; 1992 Oct; 10(10):1624-34. PubMed ID: 1403040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
    Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
    Lum BL; Kaubisch S; Fisher GA; Brown BW; Sikic BI
    Cancer Chemother Pharmacol; 2000; 45(4):305-11. PubMed ID: 10755319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdialysis assessment of microfibrous collagen containing a P-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etoposide.
    Sato H; Kitazawa H; Adachi I; Horikoshi I
    Pharm Res; 1996 Oct; 13(10):1565-9. PubMed ID: 8899852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a P-glycoprotein modulator on the pharmacokinetics and distribution of free levobupivacaine and bupivacaine in rats.
    Wu YT; Kao YL; Lin LC; Tsai TH
    Int J Pharm; 2010 Aug; 396(1-2):127-33. PubMed ID: 20600721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.
    Lacayo NJ; Lum BL; Becton DL; Weinstein H; Ravindranath Y; Chang MN; Bomgaars L; Lauer SJ; Sikic BI; Dahl GV
    Leukemia; 2002 May; 16(5):920-7. PubMed ID: 11986955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.
    Venkatakrishnan K; Tseng E; Nelson FR; Rollema H; French JL; Kaplan IV; Horner WE; Gibbs MA
    Drug Metab Dispos; 2007 Aug; 35(8):1341-9. PubMed ID: 17470526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
    Bartlett NL; Lum BL; Fisher GA; Brophy NA; Ehsan MN; Halsey J; Sikic BI
    J Clin Oncol; 1994 Apr; 12(4):835-42. PubMed ID: 8151326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.
    Syvänen S; Blomquist G; Sprycha M; Höglund AU; Roman M; Eriksson O; Hammarlund-Udenaes M; Långström B; Bergström M
    Neuroimage; 2006 Sep; 32(3):1134-41. PubMed ID: 16857389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study.
    Tsai PL; Tsai TH
    Planta Med; 2004 Nov; 70(11):1069-74. PubMed ID: 15549664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80.
    Ellis AG; Crinis NA; Webster LK
    Cancer Chemother Pharmacol; 1996; 38(1):81-7. PubMed ID: 8603456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pefloxacin and its interaction with cyclosporin A, a P-glycoprotein modulator, in rat blood, brain and bile, using simultaneous microdialysis.
    Tsai TH
    Br J Pharmacol; 2001 Mar; 132(6):1310-6. PubMed ID: 11250882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations.
    Yadav S; Pawar G; Kulkarni P; Ferris C; Amiji M
    J Pharmacol Exp Ther; 2019 Sep; 370(3):843-854. PubMed ID: 30591529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of kadsurenone and its interaction with cyclosporin A in rats using a combined HPLC and microdialysis system.
    Huang SP; Lin LC; Wu YT; Tsai TH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):247-52. PubMed ID: 19111511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study.
    Tsai TH; Liu SC; Tsai PL; Ho LK; Shum AY; Chen CF
    Br J Pharmacol; 2002 Dec; 137(8):1314-20. PubMed ID: 12466241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.